Worldwide Infertility Treatment Industry to 2026 - Rise in Unemployment Amidst Economic Fallout from COVID-19 Push Couples to Consider Delaying Parenthood Plans - ResearchAndMarkets.com
Amid the COVID-19 crisis, the global market for Infertility Treatment estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$2.1 Billion by 2026, growing at a CAGR of 6.7% over the analysis period.
Equipment, one of the segments analyzed in the report, is projected to grow at a 6.6% CAGR to reach US$1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Media & Consumables segment is readjusted to a revised 7.2% CAGR for the next 7-year period. This segment currently accounts for a 36.4% share of the global Infertility Treatment market.
The U.S. Market is Estimated at $340.6 Million in 2021, While China is Forecast to Reach $462.7 Million by 2026
The Infertility Treatment market in the U.S. is estimated at US$340.6 Million in the year 2021. The country currently accounts for a 22.64% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$462.7 Million in the year 2026 trailing a CAGR of 8.1% through the analysis period.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.5% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6% CAGR while Rest of European market (as defined in the study) will reach US$502.2 Million by the end of the analysis period. Developing countries are augmenting research in the areas of infertility, as the infertility burden is highest in developing regions.
Accessories Segment to Reach $387.9 Million by 2026
In the global Accessories segment, USA, Canada, Japan, China and Europe will drive the 5.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$220.3 Million in the year 2020 will reach a projected size of US$323.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$47.5 Million by the year 2026, while Latin America will expand at a 6.2% CAGR through the analysis period.
Select Competitors (Total 67 Featured) -
Cook Group Incorporated
CooperSurgical Fertility & Genomic Solutions
Esco Micro Pte. Ltd
Ferring B.V.
FUJIFILM Irvine Scientific
Genea Limited
Hamilton Thorne, Inc
Ihmedical A/S
INVO Bioscience
IVFTech Aps
Kitazato Corporation
LABOTECT GMBH
Medgyn Products, Inc
Merck KGaA
Rocket Medical PLC
Somatex Medical Technologies GmbH
Thermo Fisher Scientific
Vitrolife AB
ZEISS International
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Infertility Treatment - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Infertility Emerges Into a Global Health Issue
How Are Total Fertility Rates Calculated & What They Really mean?
Indications that Fertility Levels Are Continuing to Dip
Age, a Key Determinant of Fertility
COVID-19 Pandemic Disrupts Routine Healthcare, Elicits US$89.5 Million Losses in Infertility Treatment Revenues
How the COVID-19 Pandemic Destroyed the Global Economy
COVID-19 Leaves the World in Shambles & Industries and Markets Upended: World Economic Growth Projections (Real GDP, Annual % Change) for 2019, 2020 & 2021
Amid This Public Health Crisis of Unimagined Magnitude, Non-COVID-19 Healthcare Faces the Brunt of Disruptions
COVID-19 Impact on Healthcare Can be See in the Decline in Number of Non-Essential Surgeries: Annual General Surgeries Performed Worldwide (In Million)
Rise in Unemployment Amidst Economic Fallout from Covid-19 Push Couples to Consider Delaying Parenthood Plans
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Global Market Outlook 2020 & Beyond
A Peek Into Regional Dynamics
An Analysis of Growth Prospects in the Artificial Insemination Market
Infertility Treatment Options Expands to Include Surrogate Motherhood
Surrogacy: Types, Process & Cost
Surrogacy Fertility Tourism
Ethical & Legal Dilemmas
Mushrooming of Fertility Clinics to Benefit Market Growth
Private Investments in Fertility Clinic Chains Increases
Infertility Clinics Adopt Automation Technologies to Enhance Effectiveness of In-Vitro Fertilization Procedures
With Obesity Impairing Fertility, Rising Obesity Rates Are Pushing UP Demand for Fertility Treatment
Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
Endometriosis is One of the Most Common Causes of Infertility
Supported by Myriad Factors, IVF Witnesses the Highest Growth
Technology Innovation, Research & Equipment Automation Gain Momentum
Fertility Medical Tourism Continues to Rise Amid Controversies
Spain, the Preferred Country for Fertility Tourism
Changing Laws Bring Other Countries Into the Spotlight
Male Infertility, A Traditionally Under Researched Area Gains Attention
TEX101 as Potential Biomarker of Male Infertility
Home Based Semen Analysis Gains in Prominence
Global Innovations in Fertility Treatments Crucial for Continued Growth of the Market
Novel Techniques of Sperm Selection
Advancements in Chromosome Testing
Digital Technologies Like Artificial Intelligence Come to the Aid for Improving Success Rates
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwardsProvides Novavax with cash and an equity investment totalling approximately $1.2 billion...
Star Asia Group is pleased to announce that it has entered into a share transfer agreement with Minacia Co., Ltd. ("Minacia") on April 26, 2024, to acquire 100% of the shares of Minacia.
1? Reason for Share Acquisition
Star Asia Group believes that...
In the Company's announcement dated May 9, 2024, the 2023 comparative year EBITDA was corrected from $33.2 million to $44.8 million. The complete correct press release follows: Q1 2024 Financial Highlights(1): Revenues of $602.5 millionGross Margin...
Afya Limited ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2024 (first quarter 2024)....
Source Energy Services Ltd. ("Source" or the "Company") is pleased to announce its financial results for the three months ended March 31, 2024. Q1 2024 PERFORMANCE HIGHLIGHTS Key achievements for the quarter ended March 31, 2024 include the...